跳至主要内容
临床试验/ACTRN12623000472673
ACTRN12623000472673进行中(未招募)Unknown

Pilot randomized controlled trial (RCT) to test the acceptability, feasibility and potential efficacy of the SAMSON (Safety and Adherence to Medications and Self-care advice in Oncology) intervention solution in adults with haematological, lung or melanoma cancers (Short title: SAMSON pilot RCT)

Peter MacCallum Cancer Centre0 个研究点目标入组 31 人开始时间: 2023年5月9日最近更新:
适应症

试验速览

阶段
Unknown
状态
进行中(未招募)
发起方
入组人数
31

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Educational / counselling / training
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1)A confirmed diagnosis of any-stage haematological, lung or melanoma cancer;
  • 2)Scheduled to commence oral anti-cancer treatment as part of routine care or commencing treatment/currently treated with the medication for less than 12 months;
  • 3)Willing to have oral anti-cancer medication dispensed at Peter Mac;
  • 4)18 years or over;
  • 5)Proficient in English; and
  • 6)Accessibility to the internet and a smartphone and/or computer and telehealth.

排除标准

  • 1)Too unwell to participate in the study as determined by the patient’s treatment team.
  • 2)Remaining indication treatment period of oral medications for cancer therapy is less than 12 weeks.
  • 3)Demonstrated cognitive or psychological difficulties that would preclude study participation as defined by the treatment team’s cognitive and/or psychiatric assessment or patient’s disclosed medical history.

研究者

发起方
Peter MacCallum Cancer Centre

相似试验